| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 405 |
| 1 | PREDNISONE | 393 |
| 2 | METHOTREXATE | 373 |
| 3 | ADALIMUMAB | 338 |
| 4 | ACETAMINOPHEN | 268 |
| 5 | DEXAMETHASONE | 242 |
| 6 | DEXAMETHASONE 1.5 MG | 242 |
| 7 | ETANERCEPT | 218 |
| 8 | RITUXIMAB | 213 |
| 9 | PREDNISOLONE | 207 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZONGERTINIB | 4 | 0.0240 |
| 1 | CERLIPONASE ALFA | 8 | 0.0149 |
| 2 | VANCOMYCIN HYDROCHLORIDE | 124 | 0.0148 |
| 3 | MANGANESE CHLORIDE | 3 | 0.0109 |
| 4 | FLUCYTOSINE | 15 | 0.0106 |
| 5 | TOFERSEN | 5 | 0.0088 |
| 6 | HUMAN IMMUNOGLOBULIN G | 154 | 0.0074 |
| 7 | PSYLLIUM HUSK | 9 | 0.0067 |
| 8 | METHYLPREDNISOLONE ACETATE | 49 | 0.0060 |
| 9 | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | 34 | 0.0053 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 982 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 558 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 524 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 385 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 373 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 335 |
| 6 | Benzodiazepine [EPC] | 269 |
| 7 | Alkylating Drug [EPC] | 242 |
| 8 | Kinase Inhibitor [EPC] | 240 |
| 9 | Human Immunoglobulin G [EPC] | 222 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 15 | 0.0218 |
| 1 | Nucleoside Analog Antifungal [EPC] | 15 | 0.0106 |
| 2 | Human Immunoglobulin G [EPC] | 222 | 0.0105 |
| 3 | Tubulin Inhibiting Agent [EPC] | 2 | 0.0069 |
| 4 | Neonatal Fc Receptor Blocker [EPC] | 24 | 0.0055 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 31 | 0.0053 |
| 6 | Provitamin D2 Compound [EPC] | 118 | 0.0040 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 373 | 0.0038 |
| 8 | Complement Inhibitor [EPC] | 202 | 0.0036 |
| 9 | Adrenocorticotropic Hormone [EPC] | 3 | 0.0034 |